To further characterize the impact of DSCAM-AS1 on cancer phenotype, we performed a mouse xenograft tumour growth assay, showing that loss of DSCAM-AS1 reduces the growth of implanted T47D cells in vivo (Fig. 3h). Here, DSCAM-AS1 is linked to neoplasm.